F
Faheem
Birla Institute of Technology and Science, Pilani
Research areas: Medicine · Infectious Diseases · Computational Drug Discovery Methods · SARS-CoV-2 and COVID-19 Research · Synthesis and biological activity
Employment
-
Birla Institute of Technology & Science Pilani Project Fellow2021 - 2022
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (24)
- In Vitro Evaluation of PARP1 Inhibitor Olaparib‐Cyanine Dye Conjugate for the Treatment of Glioblastoma Save
- Sirtuin 6 is a histone delactylase Save
- Sirtuin 6 is a histone delactylase Save
- Fathoming the Role of mTOR in Diabetes Mellitus and its Complications Save
- Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds Save
- Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents Save
- CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 Save
- Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection Save
- Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 Save
- CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 Save
- Systematic Down-Selection of Repurposed Drug Candidates for COVID-19 Save
- Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 Infection Save
- Anti-infective Potential of Manzamine Alkaloids - A Review Save
- Design and study of novel chromone and thiochromone derivatives as PfLDH inhibitors — computational approach Save
- Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: An overview Save
- Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases Save
- 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design Save
- Anti-Tubercular Insights of Carbolines – A Decade Critique Save
- Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies Save
- Quinoline-Proline, Triazole Hybrids: Design, Synthesis, Antituberculosis, Molecular Docking, and ADMET Studies Save